Latest advances and outcomes from the treatment of acute leukemia today
Leukemia is a blood cancer that can be identified by the rapid growth of defective
blood cells. The marrow of our bone produces most of the blood in our body which is
the site of this abnormal growth. Typically, leukemia cells are immature white blood
cells. Leukemic cells alter the normal blood cell formation process, leading to various
signs and symptoms such as bleeding, infection, and tiredness.
There are two kinds of leukemia: acute leukemia and chronic leukemia. Further, the
acute type was classified into acute myeloid leukaemia (AML) and acute
lymphoblastic leukaemia (ALL). Myeloblasts, or defective white blood cells, are the
cause of acute myeloid leukaemia (AML). Acute myelogenous, granulocytic,
nonlymphocytic, or myeloblastic leukaemia are other terms for this kind of cancer.
However, the overproduction of lymphocytes is caused by acute lymphoblastic
leukaemia (ALL).
Stem cell transplantation, radiation therapy, and chemotherapy have been the
cornerstones of leukaemia treatment. Targeted therapy has also been included in the
standard of care for certain kinds of leukaemia within the past 20 years. These
medications target the proteins that regulate the growth, division, and metastasis of
cancer cells. Different treatment combinations are needed for different forms of
leukaemia.
For Acute lymphocytic leukemia (ALL), Immunotherapies are being used where
many elderly people are unable to handle the severe side effects of the intense
chemotherapy therapies required to treat ALL. Compared to chemotherapy, targeted
therapies might have fewer adverse effects.
Immunotherapies are treatments that enhance the body's ability to fight cancer
through the immune system. Currently, four immunotherapies are FDA approved for
the treatment of ALL: blinatumomab, inotuzumab ozogamicin, tisagenlecleucel and
midostaurin. In ALL, the following immunotherapy techniques are being tested or
employed are CAR T-cell therapy and bispecific T-cell engagers (BiTEs). A sort of
cancer treatment called CAR T-cell therapy involves genetically modifying the
patient & own immune cells. For the treatment of some children and young adults with
ALL, one kind of CAR T cell therapy is currently approved. Dosing is based on
weight reported at the time of leukapheresis.The use of this type in elderly B-cell
ALL patients is now being investigated. Adults with B-cell precursor ALL who have
not responded to previous treatment or have returned after treatment have been
approved for another course of CAR T-cell therapy.
Bispecific T-cell engagers (BiTEs) are another immunotherapy that is being studied
for ALL. These medications bind to both cancer and immune cells, drawing the two
groups of cells closer together so that the immune cells can locate and eliminate the
cancer cells with ease. Recently, it was demonstrated that one such BiTE,
blinatumomab, can increase survival for ALL patients in remission following
chemotherapy, even in situations where the disease is completely eradicated.
Acute myeloid leukaemia (AML) tends to be aggressive and was harder to treat than
ALL. However, AML cells sometimes have gene changes that cause the tumors to
grow but can be targeted with new drugs. The management of AML involves two
phases such as remission induction therapy (first phase of treatment to kill
the leukemia cells in the blood and bone marrow ) and remission continuation therapy
(second phase of treatment to kill any remaining leukemia cells).
The treatment of AML includes chemotherapy (drugs to stop the growth of cancer
cells), radiation therapy (uses high-energy x-rays or other types of radiation to kill
cancer cells), stem cell transplant (to replace the blood-forming cells from the blood
or bone marrow of the patient) and targeted therapy (drugs or other substances to
identify and attack specific cancer cells) or combination of both. Targeted treatments
such as Enasidenib, Olutasidenib, Ivosidenib, Venetoclax, Gemtuzumab ozogamicin,
Midostaurin, Gilteritinib, Glasdegib, and Quizartinib have recently been approved to
treat AML with specific gene alterations.
In order to achieve complete remission (CR) from acute leukaemia, standard
treatment paradigms have involved high-intensity induction chemotherapy. In certain
cases, this was followed by an allogeneic hematopoietic cell transplant (allo-HCT) to
eliminate residual disease through the "graft versus leukaemia effect, which is
mediated by the immune cells of the donor. Allo-HCT is not recommended for all
patients, though, and one of the biggest problems facing the industry at the moment is
the lack of viable chemotherapy-based choices for patients who relapse after allo-
HCT or who develop chemotherapy-refractory illness.
The potential of immunotherapy in the treatment of acute myeloid leukaemia (AML)
has been established by the effectiveness of allogeneic stem cell transplantation.
Alternative T-cell-based immunotherapies have demonstrated effectiveness, but there
is a chance that they could cause on-target off-leukemia hematotoxicity. Currently,
the use of adoptive autologous or allogeneic chimeric antigen receptor (CAR) T /
natural killer cell treatment as a bridge-to-transplant approach is almost only available
in clinical studies.
Acute leukaemia used to be nearly always fatal, but now it has a 63% 5-year survival
rate in the US. The therapeutic options for acute leukaemia have increased with the
introduction of immunotherapy, however, the advancement in AML has been slower.
Novel medicines such as ADCs, CAR T cell treatments, and BiTEs continue to show
remarkable response rates and favourable toxicity profiles in various disease states
every year. Even with these developments, a large number of patients are still not
eligible for immunotherapeutic treatments, and relapses following some of the more
recent modalities are still linked to extremely poor prognoses. In the future, new
medicines with potentially unique mechanisms of action will probably be approved
together with the expansion of the indications for currently available medications.
References:
1. Leukemia. National Cancer Institute. Available at:
https://www.cancer.gov/types/leukemia/hp/adult-aml-treatment-pdq
2. Boyiadzis MM, Aksentijevich I, Arber DA, et al. The Society for Immunotherapy
of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of
acute leukemia. Journal for ImmunoTherapy of Cancer. 2020
3. Kantarjian, H., Kadia, T., DiNardo, C. et al. Acute myeloid leukemia: current
progress and future directions. Blood Cancer J. 2021
4. Subklewe M, Bücklein V, Sallman D, Daver N. Novel immunotherapies in the
treatment of AML: is there hope? Hematology Am Soc Hematol Educ Program. 2023
Dec 8;2023
Share:
More Posts
Why Early Detection Saves Lives: The Importance of Regular Breast Screening
Breast cancer is one of the most common cancers affecting women today—but the good news is that early detection can save lives. At Healius Cancer & Hematology Clinics, we believe awareness, timely screening, and expert care are the strongest tools in the fight against breast cancer. Understanding Early Breast Cancer Signs Recognizing early breast cancer signs in Bangalore can make a major difference in treatment success. Common breast cancer symptoms include: If you notice any of these breast cancer symptoms in Bangalore, it’s essential to get evaluated immediately at a trusted breast cancer screening center. Why Early Detection Matters When detected early, breast cancer can often be treated effectively, with better outcomes and less aggressive therapies. Regular breast cancer screening in Bangalore—including mammograms and clinical breast exams—helps identify changes before symptoms appear.Early-stage diagnosis also means: At Healius, we emphasize preventive screenings and awareness programs to encourage women to take charge of their breast health. Healius – Your Partner in Breast Cancer Care Healius Cancer & Hematology Clinics is recognized among the best breast cancer hospitals in Bangalore, offering comprehensive care from diagnosis to recovery. Our expert team, led by renowned breast cancer specialists and oncologists in Bangalore, ensures each patient receives personalized, compassionate, and evidence-based treatment. We provide a full range of breast cancer treatments in Bangalore, including: Breast Cancer Screening at Healius Our breast cancer screening centers in Bangalore are equipped with cutting-edge technology for early and accurate detection. We recommend: At Healius, screening isn’t just a test—it’s a step towards empowerment and prevention. Take Action Today Breast cancer caught early is breast cancer that can be treated effectively. Don’t wait for symptoms to appear. Visit Healius Cancer & Hematology Clinics—one of the best breast cancer hospitals in Bangalore—for expert consultation, screening, and care. Your health is in your hands—schedule your breast cancer screening in Bangalore today and take the first step toward a safer, healthier future. Contact: 9900613143 Location : Banashankari 2nd stage
Simple Lifestyle Changes to Lower Your Breast Cancer Risk
Breast cancer remains one of the most common cancers among women today—but the encouraging fact is that many risk factors can be managed through healthy lifestyle choices. At Healius Cancer & Hematology Clinics, we are committed to helping women make informed decisions about their breast health through awareness, early detection, and expert oncology care. Understanding Lifestyle Risks for Breast Cancer Several lifestyle risks for breast cancer in Bangalore are linked to daily habits and overall health. While not all cases are preventable, reducing these risks can make a significant difference. Key modifiable risk factors include: Making small but consistent changes in these areas can have a big impact on prevention. Start with Awareness: Know the Early Signs Recognizing early breast cancer signs in Bangalore is crucial for timely medical attention. Watch for: If you notice any of these, reach out to Healius for a detailed check-up. Breast Self-Examination – A Simple, Life-Saving Habit Performing a breast self-examination once a month helps detect changes early. Follow our breast self-examination guide in Bangalore: Our specialists at Healius Cancer & Hematology Clinics can demonstrate proper techniques and guide you through next steps if any abnormalities are detected. Schedule Regular Screenings Early detection saves lives. Women over 40—or those with a family history of breast cancer—should schedule annual screenings at trusted mammography centers in Bangalore. At Healius, our advanced imaging facilities ensure accurate results and early diagnosis. We also maintain transparent communication about the breast cancer diagnosis cost in Bangalore, helping patients access quality care without financial stress. Expert Care and Oncology Reviews at Healius Healius is known for its patient-centered approach and trusted oncology reviews in Bangalore. Our experienced oncologists provide personalized prevention plans, screening advice, and treatment guidance based on your health profile and lifestyle. Whether you’re coming in for a routine mammogram or a full evaluation, our goal is to empower you with knowledge and proactive care. Take Control of Your Breast Health Today Your lifestyle choices matter. With regular self-exams, screenings, and small daily habits, you can significantly lower your breast cancer risk. Visit Healius Cancer & Hematology Clinics—your trusted partner for prevention, diagnosis, and treatment. Take the first step today by scheduling your screening at one of our mammography centers in Bangalore and begin your journey toward better breast health. Book an appointment : 9900613143 Location : Banashankari 2nd stage, Bangalore
The APL Paradigm: Precision, Cure, and Hope in India
APL is a subtype of AML in which immature white blood cells, called promyelocytes, build up in the bone marrow and blood. These abnormal cells prevent the production of healthy blood cells, leading to problems such as anaemia, infections, and bleeding. Acute Promyelocytic Leukaemia (APL) stands as a testament to the power of precision medicine. Once a medical emergency with a dire prognosis, it is now one of the most curable forms of adult leukaemia. This transformation, driven by genomics and targeted therapy, offers a critical model for the future of cancer care, particularly in the Indian context. Signs and Symptoms Patients with APL often present with symptoms related to low blood counts and a high risk of bleeding, which can be life-threatening if untreated. Common features include: Because of the high risk of severe bleeding, APL is considered a medical emergency and requires urgent treatment. Diagnosis Doctors use several tests to confirm APL: Early diagnosis is crucial to prevent bleeding complications. The Genomic Clarity of APL The success of APL treatment stems from a fundamental discovery: its genetic consistency. In over 98% of cases, a single genetic alteration defines the disease—a translocation between chromosomes 15 and 18, creating the PML-RARα fusion gene. This gene acts as a master switch, blocking the maturation of white blood cells. This clear, singular target made the development of targeted therapies possible. A Revolution in Targeted Treatment Instead of broad-acting chemotherapy, APL is treated with agents designed to correct this specific genetic error. The Indian Landscape: Data and Delivery GLOBOCAN data underscores the burden of leukaemia in India. For APL, this highlights a dual reality: At Healius, we have integrated this protocol as a standard of care, demonstrating that global treatment benchmarks can be successfully met within the Indian healthcare system. A Considered Conclusion The story of APL is more than a single success; it is a paradigm. It proves that understanding cancer at a genomic level lead to profoundly effective, targeted treatments. It offers a clear vision for the future of oncology and, more importantly, provides immediate and tangible hope for our patients today. A Message of Hope From your care team at Healius, A diagnosis of Acute Promyelocytic Leukaemia (APL) is serious, but it comes with a very important reason for hope: APL is now highly curable. We understand this because we know its exact genetic cause. This knowledge allows us to use targeted “smart” medicines (ATRA and Arsenic) that fix the specific problem in the blood cells. This treatment is highly effective and gentler than old-fashioned chemotherapy. In India, these medicines are accessible and affordable. Our focus at Healius is on a swift, accurate diagnosis and starting this proven treatment immediately. Our goal is your cure, and with APL, that goal is firmly within reach.
Diet and Lifestyle Tips to Lower Prostate Cancer Risk
Prostate cancer is one of the most common cancers affecting men worldwide, and its incidence is steadily rising in India. While factors like age and genetics play a role, research shows that a healthy lifestyle and diet can significantly reduce the risk of prostate cancer and support overall prostate health. At Healius Cancer & Hematology Clinics, we believe that prevention and awareness are just as important as treatment. If you are looking for guidance, support, or the best prostate cancer treatment in Bangalore, our expert team of specialists can help you with comprehensive care. 1. Eat a Balanced, Plant-Rich Diet A diet rich in fruits, vegetables, and whole grains provides antioxidants that help fight cancer-causing free radicals. Foods like tomatoes (rich in lycopene), broccoli, pomegranate, and green tea have been linked to better prostate health. 2. Choose Healthy Fats Replace saturated fats (found in red meat and fried foods) with healthier options like olive oil, nuts, seeds, and avocados. Omega-3 fatty acids, found in salmon, flaxseeds, and walnuts, are especially beneficial for prostate health. 3. Maintain a Healthy Weight Obesity has been linked to aggressive forms of prostate cancer. Regular exercise combined with mindful eating can help maintain a healthy body weight, reducing the risk. Aim for at least 30 minutes of physical activity daily. 4. Stay Active with Regular Exercise Physical activity boosts immunity, improves hormone balance, and lowers inflammation — all of which can help reduce cancer risk. Activities like brisk walking, swimming, or yoga can make a big difference in long-term health. 5. Limit Red Meat and Processed Foods Reducing red and processed meats while increasing plant-based proteins such as legumes and lentils helps lower cancer risks. Processed foods often contain harmful additives and preservatives that can negatively impact health. 6. Go for Regular Screenings Lifestyle choices are powerful, but regular check-ups with a prostate specialist in Bangalore ensure early detection. Prostate-specific antigen (PSA) tests and routine screenings are recommended, especially for men over 50 or those with a family history of prostate cancer. Why Choose Healius for Prostate Cancer Care? At Healius Cancer & Hematology Clinics, we provide a holistic approach that combines advanced medical treatments with preventive care. Whether you need routine screenings, lifestyle counseling, or advanced treatment, our experienced team ensures personalized care. Final Thoughts While diet and lifestyle changes play a crucial role in lowering prostate cancer risk, timely medical guidance is equally important. If you or a loved one are seeking expert care, Healius Cancer & Hematology Clinics is here to support you with compassionate, comprehensive, and cutting-edge treatment options. 📞 Book a consultation today with the best prostate cancer doctors in Bangalore at Healius and take a proactive step toward better prostate health. Contact : +91 99006-13143 Location : Banashankari 2nd stage
